NASDAQ:CURX | News | Curanex Pharmaceuticals Inc

CURX News

Official issuer or fund updates, exact SEC current reports, and large established publisher coverage, newest first. Every lawfully retained item remains in the corpus; each public page contains at most 100 rows. Headlines open the exact source; summaries are concise descriptions and not investment recommendations. Captured 2026-08-31.

DateTypePublisherHeadlineSummary
2026-08-17Current reportSEC filingCuranex Pharmaceuticals Inc filed Form 8-KCuranex Pharmaceuticals Inc filed Form 8-K covering items 3.03,5.03,9.01.
2026-05-14Current reportSEC filingCuranex Pharmaceuticals Inc filed Form 8-KCuranex Pharmaceuticals Inc filed Form 8-K covering items 7.01,9.01.
2026-05-07Current reportSEC filingCuranex Pharmaceuticals Inc filed Form 8-KCuranex Pharmaceuticals Inc filed Form 8-K covering items 8.01.
2026-04-02Current reportSEC filingCuranex Pharmaceuticals Inc filed Form 8-KCuranex Pharmaceuticals Inc filed Form 8-K covering items 7.01,9.01.
2026-03-06Current reportSEC filingCuranex Pharmaceuticals Inc filed Form 8-KCuranex Pharmaceuticals Inc filed Form 8-K covering items 1.01,5.02,9.01.
2026-01-05Current reportSEC filingCuranex Pharmaceuticals Inc filed Form 8-KCuranex Pharmaceuticals Inc filed Form 8-K covering items 5.02,9.01.
2025-11-06Current reportSEC filingCuranex Pharmaceuticals Inc filed Form 8-KCuranex Pharmaceuticals Inc filed Form 8-K covering items 3.01.
2025-09-29Current reportSEC filingCuranex Pharmaceuticals Inc filed Form 8-KCuranex Pharmaceuticals Inc filed Form 8-K covering items 3.02,8.01,9.01.
2025-09-12Current reportSEC filingCuranex Pharmaceuticals Inc filed Form 8-KCuranex Pharmaceuticals Inc filed Form 8-K covering items 8.01,9.01.
2025-08-27Current reportSEC filingCuranex Pharmaceuticals Inc filed Form 8-KCuranex Pharmaceuticals Inc filed Form 8-K covering items 8.01,9.01.
2025-08-26Current reportSEC filingCuranex Pharmaceuticals Inc filed Form 8-KCuranex Pharmaceuticals Inc filed Form 8-K covering items 1.01,8.01,9.01.